Pathogenicity and Virulence Factors: Article review
DOI:
https://doi.org/10.55544/sjmars.4.6.8Keywords:
Pathogenicity, virulence, Susceptibility, Genetic, speciesAbstract
A rephrasing of the words "pathogenicity" or "virulence" as they relate to invertebrates disease has been suggested in a recently released investigation that questioned their coherence or intelligibility. Examining the meanings of pathogenicity as well as virulence as they apply to invertebrate disease was our objective, along with providing feedback on this work.
The words "pathogenicity" or "virulence" are used differently, despite there is a fair amount of agreement in the explanations that have been written in research on invertebrates pathologies all through the course of the field's past times, as well as in allied fields like microbiological or medical. Researchers did not see any lack of transparency and usefulness in the defined criteria. As a result, they advise that the meaning or use of these words follow precedent. Could be more precise, pathogenicity is the circumstance or attribute that renders something pathogenic, the capacity to cause illness, while virulence is the capability of the living thing can cause illness, the level of pathogenicity inside a species and group. Virulence is a phrase which assesses disease transmission, while pathogenicity is a qualitative, "all-or-none" notion.
References
[1] Diep BA, Le VT, Badiou C, et al. IVIG-mediated Protection against Necrotizing Pneumonia Caused by MRSA. Sci Transl Med. 2016;8(357):357ra124.
[2] Piewngam P, Zheng Y, Nguyen TH, et al. Pathogen elimination by probiotic Bacillus via signalling interference. Nature. 2018;562(7728):532–537.
[3] Parlet CP, Kavanaugh JS, Crosby HA, et al. Apicidin Attenuates MRSA Virulence through Quorum-Sensing Inhibition and Enhanced Host Defense. Cell Rep. 2019;27(1):187–98 e6.
[4] Sully EK, Malachowa N, Elmore BO, et al. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog. 2014;10(6):e1004174.
[5] Tuchscherr L, Bischoff M, Lattar SM, et al. Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections. PLoS Pathog. 2015;11(4):e1004870.
[6] Dickey SW, Cheung GYC, Otto M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017;16(7):457–471.
[7] Diep BA, Hilliard JJ, Le VT, et al. Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia. Antimicrob Agents Chemother. 2017;61:4.
[8] Yu XQ, Robbie GJ, Wu Y, et al. Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults. Antimicrob Agents Chemother. 2017;61:1.
[9] Rouha H, Badarau A, Visram ZC, et al. Five birds, one stone: neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs. 2015;7(1):243–254.
[10] Stulik L, Rouha H, Labrousse D, et al. Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid. Sci Rep. 2019;9(1):5339.
[11] Li L, Wang G, Cheung A, et al. MgrA Governs Adherence, Host Cell Interaction, and Virulence in a Murine Model of Bacteremia Due to Staphylococcus aureus. J Infect Dis. 2019;220(6):1019–1028.
[12] Liu Q, Yeo WS, Bae T. The SaeRS Two-Component System of Staphylococcus aureus. Genes (Basel). 2016;7:10.
[13] Tiwari N, Lopez-Redondo M, Miguel-Romero L, et al. The SrrAB two-component system regulates Staphylococcus aureus pathogenicity through redox sensitive cysteines. Proc Natl Acad Sci U S A. 2020;117(20):10989–10999.
[14] He L, Le KY, Khan BA, et al. Resistance to leukocytes ties benefits of quorum sensing dysfunctionality to biofilm infection. Nat Microbiol. 2019;4(7):1114–1119.
[15] Nakamura Y, Takahashi H, Takaya A, et al. Staphylococcus Agr virulence is critical for epidermal colonization and associates with atopic dermatitis development. Sci Transl Med. 2020;12:551.
[16] 240 Pollitt EJ, West SA, Crusz SA, et al. Cooperation, quorum sensing, and evolution of virulence in Staphylococcus aureus. Infect Immun. 2014;82(3):1045–1051.
[17] Williams MR, Costa SK, Zaramela LS, et al. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis. Sci Transl Med. 2019;11:490.
[18] Cheung GY, Wang R, Khan BA, et al. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun. 2011;79(5):1927–1935.
[19] Joo HS, Otto M. Toxin-mediated gene regulatory mechanism in Staphylococcus aureus. Microb Cell. 2016;4(1):29–31.
[20] Le KY, Otto M. Quorum-sensing regulation in staphylococci-an overview. Front Microbiol. 2015;6:1174.
[21] Katayama Y, Baba T, Sekine M, et al. Beta-hemolysin promotes skin colonization by Staphylococcus aureus. J Bacteriol. 2013;195(6):1194–1203.
[22] Langley R, Patel D, Jackson N, et al. Staphylococcal superantigen super-domains in immune evasion. Crit Rev Immunol. 2010;30(2):149–165.
[23] Nguyen MT, Kraft B, Yu W, et al. The nuSaalpha Specific Lipoprotein Like Cluster (lpl) of S. Aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells PLoS Pathog. 2015;11(6):e1004984.
[24] Joo HS, Cheung GY, Otto M. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem. 2011;286(11):8933–8940.
[25] Novick RP, Islands P. Their Role in Staphylococcal Biology. Microbiol Spectr. 2019;7:3.
[26] Klaui AJ, Boss R, Graber HU. Characterization and Comparative Analysis of the Staphylococcus aureus Genomic Island vSabeta: an In Silico Approach. J Bacteriol. 2019;201:22.
[27] Ziegler C, Goldmann O, Hobeika E, et al. The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy. EMBO Mol Med. 2011;3(11):652–666.
[28] Tebartz C, Horst SA, Sparwasser T, et al. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J Immunol. 2015;194(3):1100–1111.
[29] Lindsay JA. Staphylococci: evolving Genomes. Microbiol Spectr. 2019;7:6.
[30] Moldovan A, Fraunholz MJ. In or out: phagosomal escape of Staphylococcus aureus. Cell Microbiol. 2019;21(3):e12997.
[31] Gonzalez CD, Ledo C, Cela E, et al. The good side of inflammation: staphylococcus aureus proteins SpA and Sbi contribute to proper abscess formation and wound healing during skin and soft tissue infections. Biochim Biophys Acta Mol Basis Dis. 2019;1865(10):2657–2670.
[32] Li M, Dai Y, Zhu Y, et al. Virulence determinants associated with the Asian community-associated methicillin-resistant Staphylococcus aureus lineage ST59. Sci Rep. 2016;6:27899.
[33] Foster TJ. The MSCRAMM Family of Cell-Wall-Anchored Surface Proteins of Gram-Positive Cocci. Trends Microbiol. 2019;27(11):927–941.
[34] Berlon NR, Qi R, Sharma-Kuinkel BK, et al. Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins. J Infect. 2015;71(4):447–457.
[35] Grosz M, Kolter J, Paprotka K, et al. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell Microbiol. 2014;16(4):451–465.
[36] Munzenmayer L, Geiger T, Daiber E, et al. Influence of Sae-regulated and Agr-regulated factors on the escape of Staphylococcus aureus from human macrophages. Cell Microbiol. 2016;18(8):1172–1183.
[37] Winstel V, Schneewind O, Missiakas D. Staphylococcus aureus Exploits the Host Apoptotic Pathway To Persist during Infection. mBio. 2019;10:6.
[38] Graves SF, Kobayashi SD, Braughton KR, et al. Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol. 2012;92(2):361–374.
[39] Holzinger D, Gieldon L, Mysore V, et al. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J Leukoc Biol. 2012;92(5):1069–1081.
[40] Nakagawa S, Matsumoto M, Katayama Y, et al. Staphylococcus aureus Virulent PSMalpha Peptides Induce Keratinocyte Alarmin Release to Orchestrate IL-17-Dependent Skin Inflammation. Cell Host Microbe. 2017;22(5):667–77 e5.
[41] Bloes DA, Haasbach E, Hartmayer C, et al. Peptides Contribute to Influenza A Virus-Associated Staphylococcus aureus Pneumonia. Infect Immun. 2017;85:12.
[42] Boguslawski KM, McKeown AN, Day CJ, et al. Exploiting species specificity to understand the tropism of a human-specific toxin. Sci Adv. 2020;6(11):eaax7515.
[43] Spaan AN, Reyes-Robles T, Badiou C, et al. Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes. Cell Host Microbe. 2015;18(3):363–370.
[44] Kitur K, Parker D, Nieto P, et al. Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog. 2015;11(4):e1004820.
[45] Zapotoczna M, Riboldi GP, Moustafa AM, et al. Mobile-Genetic-Element-Encoded Hypertolerance to Copper Protects Staphylococcus aureus from Killing by Host Phagocytes. mBio. 2018;9:5.
[46] NWM DJ, Ramyar KX, Guerra FE, et al. Immune evasion by a staphylococcal inhibitor of myeloperoxidase. Proc Natl Acad Sci U S A. 2017;114(35):9439–9444.
[47] Kobayashi SD, Malachowa N, DeLeo FR. Neutrophils and Bacterial Immune Evasion. J Innate Immun. 2018;10(5–6):432–441.
[48] Zhang Y, Wu M, Hang T, et al. Staphylococcus aureus SdrE captures complement factor H’s C-terminus via a novel ‘close, dock, lock and latch‘ mechanism for complement evasion. Biochem J. 2017;474(10):1619–1631.
[49] Skurnik D, Cywes-Bentley C, Pier GB. The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG. Expert Rev Vaccines. 2016;15(8):1041–1053.
[50] Boyle-Vavra S, Li X, Alam MT, et al. USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. mBio. 2015;6:2.
[51] Chen X, Alonzo F 3rd.. Bacterial lipolysis of immune-activating ligands promotes evasion of innate defenses. Proc Natl Acad Sci U S A. 2019;116(9):3764–3773.
[52] Tuffs SW, James DBA, Bestebroer J, et al. The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function. PLoS Pathog. 2017;13(9):e1006461.
[53] Hanzelmann D, Joo HS, Franz-Wachtel M, et al. Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants. Nat Commun. 2016;7:12304.
[54] Krepel SA, Wang JM. Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors. Int J Mol Sci. 2019;20:14.
[55] El-Benna J, Hurtado-Nedelec M, Marzaioli V, et al. Priming of the neutrophil respiratory burst: role in host defense and inflammation. Immunol Rev. 2016;273(1):180–193.
[56] Nguyen MT, Gotz F. Lipoproteins of Gram-Positive Bacteria: key Players in the Immune Response and Virulence. Microbiol Mol Biol Rev. 2016;80(3):891–903.
[57] Pollitt EJG, Szkuta PT, Burns N, et al. Staphylococcus aureus infection dynamics. PLoS Pathog. 2018;14(6):e1007112.
[58] Surewaard BG, Deniset JF, Zemp FJ, et al. Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med. 2016;213(7):1141–1151.
[59] NWM DJ, KPM VK, van Strijp JAG. Immune Evasion by Staphylococcus aureus. Microbiol Spectr. 2019;7:2.
[60] Liu H, Archer NK, Dillen CA, et al. Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses. Cell Host Microbe. 2017;22(5):653–66 e5.
[61] Hodille E, Cuerq C, Badiou C, et al. Delta Hemolysin and Phenol-Soluble Modulins, but Not Alpha Hemolysin or Panton-Valentine Leukocidin, Induce Mast Cell Activation. Front Cell Infect Microbiol. 2016;6:180.
[62] Schlievert PM, Davis CC. Device-Associated Menstrual Toxic Shock Syndrome. Clin Microbiol Rev. 2020;33:3.
[63] Fisher EL, Otto M, Cheung GYC. Basis of Virulence in Enterotoxin-Mediated Staphylococcal Food Poisoning. Front Microbiol. 2018;9:436.
[64] Ono HK, Hirose S, Narita K, et al. Histamine release from intestinal mast cells induced by staphylococcal enterotoxin A (SEA) evokes vomiting reflex in common marmoset. PLoS Pathog. 2019;15(5):e1007803.
[65] Senn L, Clerc O, Zanetti G, et al. The Stealthy Superbug: the Role of Asymptomatic Enteric Carriage in Maintaining a Long-Term Hospital Outbreak of ST228 Methicillin-Resistant Staphylococcus aureus. mBio. 2016;7(1):e02039–15.
[66] Staphylococcal Biofilms.Microbiol Spectr. 2018;6(4).
[67] McGuinness WA, Malachowa N, DeLeo FR. Vancomycin Resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90(2):269–281.
[68] Bonesso MF, Yeh AJ, Villaruz AE, et al. Key Role of alpha-Toxin in Fatal Pneumonia Caused by Staphylococcus aureus Sequence Type 398. Am J Respir Crit Care Med. 2016;193(2):217–220.
[69] Bouiller K, Bertrand X, Hocquet D, et al. Human Infection of Methicillin-Susceptible Staphylococcus aureus CC398: a Review. Microorganisms. 2020;8:11.
[70] Kavanagh KT. Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses. Antimicrob Resist Infect Control. 2019;8:103.
[71] Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9–14.
[72] Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17(4):203–218.
[73] Kourtis AP, Hatfield K, Baggs J, et al. Emerging Infections Program Mag, Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D. Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections - United States MMWR Morb Mortal Wkly Rep. 2019;68(9):214–219.
[74] Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–661.
[75] Popov LM, Marceau CD, Starkl PM, et al. The adherens junctions control susceptibility to Staphylococcus aureus alpha-toxin. Proc Natl Acad Sci U S A. 2015;112(46):14337–14342.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stallion Journal for Multidisciplinary Associated Research Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/sjmars
editor@sjmars.com | 
+91-8874396939
